Literature DB >> 20195177

Greater exercise sweating in obese women with polycystic ovary syndrome compared with obese controls.

Nina S Stachenfeld1, Catherine Weikart Yeckel, Hugh S Taylor.   

Abstract

PURPOSE: We examined estradiol and testosterone effects on thermoregulation in women with and without Polycystic Ovary syndrome (PCOS). We hypothesized that core temperature (Tc) threshold for sweating during exercise is delayed in women with PCOS and that testosterone delays the Tc set point for sweating during exercise.
METHODS: For 16 d, we suppressed estrogens, progesterone, and testosterone with a gonadotropin-releasing hormone antagonist (GnRHant) in seven women with and seven women without PCOS (control); we added 17[beta]-estradiol (0.2 mg.d-1, two patches) on days 4-16 (E2) and testosterone (2.5 mg.d-1, orally) on days 13-16 (E2 + T). Under each hormone condition, subjects cycled in a temperature of 35 degrees C at 60% of age-predicted HRmax for 40 min.
RESULTS: Tc sweating threshold was lower in women in the PCOS group compared with those in the control during GnRHant (37.21 degrees C +/- 0.51 degrees C vs 37.70 degrees C +/- 0.12 degrees C, P < 0.05); neither E2 nor E2 + T influenced the thermoregulatory responses in PCOS. E2 decreased Tc sweating threshold in control (37.06 degrees C +/- 0.69 degrees C, P < 0.05), but E2 + T attenuated this response (37.53 degrees C +/- 0.19 degrees C). Peak sweating rate was greater in women in the PCOS group compared with those in the control group during GnRHant (1.06 +/- 0.47 vs 0.47 +/- 0.11 mg.cm-2.min-1) and E2 + T (0.85 +/- 0.41 vs 0.44 +/- 0.10 mg.cm-2.min-1, P < 0.05). Compared with the control group, total sweat losses were greater in the PCOS group during GnRHant (0.614 +/- 0.189 vs 0.419 +/- 0.098 L) and during E2 + T (0.696 +/- 0.281 vs 0.434 +/- 0.164 L, P < 0.05) but not during E2 (0.639 +/- 0.231 and 0.505 +/- 0.214 L for PCOS and control groups, respectively, P = 0.09).
CONCLUSIONS: Thermoregulation was adequate in women with PCOS; however, the women with PCOS achieved thermoregulation at the expense of producing higher sweat volumes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20195177      PMCID: PMC3109293          DOI: 10.1249/MSS.0b013e3181d8cf68

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  34 in total

1.  Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers.

Authors:  J J Oberyé; B M Mannaerts; J A Huisman; C J Timmer
Journal:  Fertil Steril       Date:  1999-12       Impact factor: 7.329

2.  Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part I. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers.

Authors:  J J Oberyé; B M Mannaerts; H J Kleijn; C J Timmer
Journal:  Fertil Steril       Date:  1999-12       Impact factor: 7.329

3.  Estrogen modifies the temperature effects of progesterone.

Authors:  N S Stachenfeld; C Silva; D L Keefe
Journal:  J Appl Physiol (1985)       Date:  2000-05

Review 4.  American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults.

Authors:  J M Jakicic; K Clark; E Coleman; J E Donnelly; J Foreyt; E Melanson; J Volek; S L Volpe
Journal:  Med Sci Sports Exerc       Date:  2001-12       Impact factor: 5.411

Review 5.  The pathophysiology of polycystic ovary syndrome.

Authors:  Tasoula Tsilchorozidou; Caroline Overton; Gerard S Conway
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

6.  Action of progesterone on preoptic thermosensitive neurones.

Authors:  T Nakayama; M Suzuki; N Ishizuka
Journal:  Nature       Date:  1975-11-06       Impact factor: 49.962

Review 7.  Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.

Authors:  M Barontini; M C García-Rudaz; J D Veldhuis
Journal:  Arch Med Res       Date:  2001 Nov-Dec       Impact factor: 2.235

8.  Differential thermal sensitivity in the human skin.

Authors:  E R Nadel; J W Mitchell; J A Stolwijk
Journal:  Pflugers Arch       Date:  1973       Impact factor: 3.657

9.  Importance of skin temperature in the regulation of sweating.

Authors:  E R Nadel; R W Bullard; J A Stolwijk
Journal:  J Appl Physiol       Date:  1971-07       Impact factor: 3.531

Review 10.  The role of lifestyle modification in polycystic ovary syndrome.

Authors:  Robert J Norman; Michael J Davies; Jonathan Lord; Lisa J Moran
Journal:  Trends Endocrinol Metab       Date:  2002-08       Impact factor: 12.015

View more
  10 in total

1.  A comparison of thermoregulatory responses to exercise between mass-matched groups with large differences in body fat.

Authors:  Sheila Dervis; Geoff B Coombs; Georgia K Chaseling; Davide Filingeri; Jovana Smoljanic; Ollie Jay
Journal:  J Appl Physiol (1985)       Date:  2015-12-23

2.  The evaporative requirement for heat balance determines whole-body sweat rate during exercise under conditions permitting full evaporation.

Authors:  Daniel Gagnon; Ollie Jay; Glen P Kenny
Journal:  J Physiol       Date:  2013-03-04       Impact factor: 5.182

3.  Running economy, not aerobic fitness, independently alters thermoregulatory responses during treadmill running.

Authors:  Jovana Smoljanić; Nathan B Morris; Sheila Dervis; Ollie Jay
Journal:  J Appl Physiol (1985)       Date:  2014-10-09

4.  Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.

Authors:  Megan M Wenner; Hugh S Taylor; Nina S Stachenfeld
Journal:  J Physiol       Date:  2011-08-08       Impact factor: 5.182

5.  Disassociation of liver and muscle insulin resistance from ectopic lipid accumulation in low-birth-weight individuals.

Authors:  Sylvie Dufour; Kitt Falk Petersen
Journal:  J Clin Endocrinol Metab       Date:  2011-10-12       Impact factor: 5.958

Review 6.  Influences of ovarian hormones on physiological responses to cold in women.

Authors:  Andrew M Greenfield; Nisha Charkoudian; Billie K Alba
Journal:  Temperature (Austin)       Date:  2021-09-14

7.  Physical activity and mental health in women with polycystic ovary syndrome.

Authors:  Lauren K Banting; Melanie Gibson-Helm; Remco Polman; Helena J Teede; Nigel K Stepto
Journal:  BMC Womens Health       Date:  2014-03-27       Impact factor: 2.809

Review 8.  Pathophysiological effects of androgens on the female vascular system.

Authors:  Tori Stone; Nina S Stachenfeld
Journal:  Biol Sex Differ       Date:  2020-07-29       Impact factor: 5.027

Review 9.  The Importance of Sleep Hygiene in Polycystic Ovary Syndrome from the View of Iranian Traditional Medicine and Modern Medicine.

Authors:  Maryam Bahman; Homa Hajimehdipoor; Maryam Afrakhteh; Soodabeh Bioos; Fataneh Hashem-Dabaghian; Mojgan Tansaz
Journal:  Int J Prev Med       Date:  2018-10-12

10.  Hypertension Predisposition and Thermoregulation Delays in Adolescents with Polycystic Ovary Syndrome: A Pilot Study.

Authors:  Styliani Geronikolou; Flora Bacopoulou; Stavros Chryssanthopoulos; Dennis V Cokkinos; George P Chrousos
Journal:  Children (Basel)       Date:  2022-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.